Skip to main content
Department of Industrial Pharmacy

Researches

The department research plan participates in solving problems that face the pharmaceutical industry in the vicinity of Asyut City and others. Staff members are also supervising and teaching post-graduate students, Diploma, MSc. and Ph.D. students, and the proposed advanced and novel specializations in pharmaceutical sciences for the next 5 years plan listed below:

  1. Targeted drug delivery using Micro-/Nan particulate technologies (Polymeric particles, micro-emulsions, liposomes, etc.)
  2. Enhancing peptide and protein drug delivery via the oral and pulmonary routes.
  3. Controlled release formulation of drugs.
  4. Enhancing drug dissolution and bioavailability.
  5. Gastro-retentive technology.
  6. Transdermal drug delivery.
# Title Research Year
31 Antibacterial Nanotruffles for Treatment of Intracellular Bacterial Infection 2020
32 Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications 2020
33 Sulpiride Gastro-retentive Floating Microsponges; Analytical study, In vitro Optimization and In vivo Characterization 2020
34 Transfersomal Gel Nanocarriers for Enhancement the Permeation of Lornoxicam 2020
35 Sulpiride Gastro-retentive Floating Microsponges; Analytical study, In vitro Optimization and In vivo Characterization 2020
36 An investigation into the impact of key process variables on the uniformity of powder blends containing a low-dose drug in a gentle-wing high shear mixer 2020
37 Transfersomal Gel Nanocarriers for Enhancement the Permeation of Lornoxicam 2020
38 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders 2020
39 Integrative physicochemical and HPLC assessment studies for the inclusion of lornoxicam in buffalo's milk fat globules as a potential carrier delivery system for lipophilic drugs 2020
40 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders 2020